News and Events


Helsinn initiates two new global Phase III studies with anamorelin

March 7th, 2019

Helsinn committed to anamorelin which is being evaluated for weight loss and anorexia in patients with advanced non small cell lung cancer (NSCLC) and...

Read article

Ten finalists have been chosen for the second annual Lyfebulb-Helsinn Innovation...

February 27th, 2019

The Award recognizes Patient Entrepreneurs’ innovations for cancer and cancer supportive care using therapeutics, diagnostics, medical devices or heal...

Read article

Helsinn Group Grants Exclusive Licensing Rights to Menarini for Pracinostat

December 21st, 2018

Licensing rights are worldwide excluding US, Canada, Japan and South America

Read article


Vitafoods Europe

  • 7th May 2019 - 9th May 2019
  • Geneva
  • Booth N165
Full event info


  • 20th March 2019 - 21st March 2019
  • New York
Full event info

CPhI Japan

  • 18th March 2019 - 20th March 2019
  • Tokyo
Full event info